S. Lightfoot

发表

Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

L. Kopelovich, S. Amin, D. Desai, 2013, Neoplasia.

Abstract 2820: Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model

V. Steele, C. Rao, J. Patlolla, 2015 .

Biomarker Identification in Human Pancreatic Cancer Sera

M. Lerner, D. Morgan, R. Postier, 2008, Pancreas.

Expression of prohibitin 3′ untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells

M. Lerner, D. Brackett, X. Zang, 2004, Journal of Molecular Histology.

Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.

Aaron J. Johnson, J. Wren, J. V. van Deursen, 2016, The Journal of clinical investigation.

Expression of the cyclin‐dependent kinase inhibitor p21WAF1/CIP1 and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus

M. Lerner, R. Postier, D. Brackett, 1999, Cancer.

Systemic molecular and cellular changes induced in rats upon inhalation of JP-8 petroleum fuel vapor

M. Lerner, D. Brackett, J. Hanas, 2010, Toxicology mechanisms and methods.

Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo

A. Reis, S. Lightfoot, S. Anant, 2012, Oncogene.

Obscure GI bleeding due to gastrointestinal stromal tumor (GIST) diagnosed by capsule endoscopy.

S. Lightfoot, R. Harty, R. Kurella, 2005, The Journal of the Oklahoma State Medical Association.

Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients

M. Lerner, R. Postier, D. Brackett, 2017, Cancer investigation.

Distinguishing Non-Small Cell Lung Adenocarcinoma Patients from Squamous Cell Carcinoma Patients and Control Individuals Using Serum Profiling

M. Lerner, D. Brackett, J. Hanas, 2012, Cancer investigation.

Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

V. Steele, C. Rao, Yuting Zhang, 2019, Cancer Prevention Research.

Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation Injury

S. Lightfoot, R. May, C. Houchen, 2015, PloS one.

Voluntary wheel running reduces colon inflammation in female but not male mice fed a high-fat diet

S. Lightfoot, L. Joseph, C. Gardner, 2019, Comparative Exercise Physiology.

Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma.

M. Lerner, R. Postier, D. Brackett, 2002, American journal of surgery.

Chemopreventive Efficacy of Raloxifene, Bexarotene, and Their Combination on the Progression of Chemically Induced Colon Adenomas to Adenocarcinomas in Rats

V. Steele, C. Rao, Yuting Zhang, 2013, Cancer Prevention Research.

Distinguishing Patients with Stage I Lung Cancer Versus Control Individuals using Serum Mass Profiling

M. Lerner, D. Brackett, J. Hanas, 2014, Cancer investigation.

Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.

I. Pastan, M. Lerner, D. Brackett, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.

K. Berlin, S. Lightfoot, S. Guruswamy, 2001, Journal of the National Cancer Institute.

Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor Cells

R. Postier, J. Hanas, J. Hocker, 2015, PloS one.

DCLK1 Is Detectable in Plasma of Patients with Barrett’s Esophagus and Esophageal Adenocarcinoma

W. Tierney, J. Maple, S. Lightfoot, 2015, Digestive Diseases and Sciences.

Distinguishing Early-Stage Pancreatic Cancer Patients From Disease-Free Individuals Using Serum Profiling

M. Lerner, R. Postier, D. Brackett, 2011, Cancer investigation.

TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma.

V. Steele, L. Kopelovich, C. Rao, 2015, American journal of cancer research.

Chemoprevention of Urothelial Cell Carcinoma Growth and Invasion by the Dual COX–LOX Inhibitor Licofelone in UPII-SV40T Transgenic Mice

V. Steele, L. Kopelovich, C. Rao, 2014, Cancer Prevention Research.

Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.

V. Steele, C. Rao, Altaf Mohammed, 2012, Neoplasia.

Evaluation of 99mTc-Probestin SPECT As a Novel Technique for Noninvasive Imaging of Kidney Aminopeptidase N Expression

C. Rao, S. Lightfoot, B. Cowley, 2014, Molecular pharmaceutics.

Serum Profiling to Distinguish Early- and Late-Stage Ovarian Cancer Patients from Disease-Free Individuals

M. Lerner, D. Brackett, J. Hanas, 2012, Cancer investigation.

Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.

M. Lerner, D. Brackett, J. Hanas, 2011, Lung cancer.

Prevention of rat mammary carcinoma utilizing leuprolide as an equivalent to oophorectomy

M. Lerner, D. Brackett, A. Hollingsworth, 1999, Breast Cancer Research and Treatment.

A Comparative Study of Modern and Heirloom Wheat on Indicators of Gastrointestinal Health.

B. Carver, S. Lightfoot, Brenda J. Smith, 2019, Journal of agricultural and food chemistry.

Flaxseed reverses atherosclerotic lesion formation and lowers lipoprotein(a) in ovarian hormone deficiency

M. Lerner, D. Brackett, S. Lightfoot, 2013, Menopause.

Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.

M. Lerner, D. Brackett, S. Lightfoot, 2006, Bone.

Soy isoflavones prevent ovariectomy-induced atherosclerotic lesions in Golden Syrian hamster model of postmenopausal hyperlipidemia

S. Lightfoot, B. Arjmandi, B. Daggy, 2003, Menopause.

Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells.

S. Lightfoot, D. Benbrook, J. Shen-Gunther, 1997, Gynecologic oncology.

Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands.

M. Lerner, D. Brackett, J. Gimble, 1998, Biochemical and biophysical research communications.

Flaxseed but not flaxseed oil prevented the rise in serum cholesterol due to ovariectomy in the Golden Syrian hamsters.

S. Lightfoot, B. Arjmandi, S. Mahajan, 2011, Journal of medicinal food.

Therapeutic treatment of DMBA-induced mammary tumors with PPAR ligands.

D. Brackett, J. Gimble, A. Hollingsworth, 2001, Anticancer research.

Laryngeal Tuberculosis Masquerading as Carcinoma

S. Lightfoot, 1997, The Journal of the American Board of Family Medicine.

Effects of N-Acetylcysteine Plus Mesalamine on Prostaglandin Synthesis and Nitric Oxide Generation in TNBS-Induced Colitis in Rats

S. Lightfoot, R. Harty, R. Kurella, 2009, Digestive Diseases and Sciences.

TNF-α mediates macrophage-induced bystander effects through Netrin-1.

S. Lightfoot, M. Huycke, Xingmin Wang, 2012, Cancer research.

Microenvironment and Immunology TNF-a Mediates Macrophage-Induced Bystander Effects through Netrin-1

S. Lightfoot, M. Huycke, Xingmin Wang, 2012 .

Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation.

M. Lerner, D. Morgan, R. Postier, 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists

K. Berlin, S. Lightfoot, S. Guruswamy, 2005, Investigational New Drugs.

Loss of natural killer T cells promotes pancreatic cancer in LSL‐KrasG12D/+ mice

C. Rao, Altaf Mohammed, S. Lightfoot, 2017, Immunology.

An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer

W. Hildebrand, S. Lightfoot, A. Rawat, 2011, The Journal of Immunology.

Impaired glucose tolerance attenuates bone accrual by promoting the maturation of osteoblasts: Role of Beclin1-mediated autophagy

S. Lightfoot, J. Ritchey, Brenda J. Smith, 2016, Bone reports.

Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model

V. Steele, C. Rao, Yuting Zhang, 2019, Cancer Prevention Research.

Successful Treatment of Helicobacter Pylori-Negative Gastric MALT Lymphoma With Rituximab

S. Lightfoot, H. Ozer, D. Huard, 2006, Digestive Diseases and Sciences.

Brief Report: Dclk1 Deletion in Tuft Cells Results in Impaired Epithelial Repair After Radiation Injury

Linheng Li, S. Lightfoot, R. May, 2014, Stem cells.

Primary mixed neuroendocrine carcinoma of the bladder with large cell component: a case report and review of the literature

S. Lightfoot, D. Culkin, G. Slobodov, 2012, International Urology and Nephrology.

p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.

L. Kopelovich, C. Rao, Yuting Zhang, 2013, Neoplasia.

cDNA cloning, DNA binding, and evolution of mammalian transcription factor IIIA.

M. Lerner, D. Brackett, J. Hanas, 2002, Gene.

Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.

V. Steele, C. Rao, Misty Brewer, 2013, Translational oncology.

Abstract 2268: Metformin prevents progression of pancreatic intraepithelial neoplasia to ductal adenocarcinoma by targeting cancer stem cells and mTOR signaling.

V. Steele, C. Rao, Misty Brewer, 2013 .

Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies.

C. Rao, Altaf Mohammed, S. Lightfoot, 2012, Current medicinal chemistry.

Abstract 2839: Licofelone, a novel dual COX-LOX inhibitor prevents progression of PanIN lesions to pancreatic carcinoma by targeting miRNAs and cancer stem cells in p48Cre/+-LSL-KrasG12D/+ transgenic mice

V. Steele, C. Rao, Altaf Mohammed, 2011 .

Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis

M. Lerner, L. Hershey, J. Hanas, 2021, Brain sciences.

Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen

M. Lerner, D. Brackett, A. Hollingsworth, 2004, Breast Cancer Research and Treatment.

Doublecortin and CaM Kinase‐like‐1 and Leucine‐Rich‐Repeat‐Containing G‐Protein‐Coupled Receptor Mark Quiescent and Cycling Intestinal Stem Cells, Respectively

S. Lightfoot, S. Anant, R. May, 2009, Stem cells.

Effects of Portabella mushrooms on collagen-induced arthritis, inflammatory cytokines, and body composition in dilute brown non-agouti (DBA1) mice

S. Lightfoot, Brenda J. Smith, E. Lucas, 2011 .

DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4

C. Rao, S. Lightfoot, C. Houchen, 2020, Molecular therapy oncolytics.

Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53

R. Pelikan, S. Lightfoot, D. Benbrook, 2019, International journal of cancer.

4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages.

S. Lightfoot, Susan L. Nimmo, M. Huycke, 2012, Gastroenterology.

Targeting cholecystokinin‐2 receptor for pancreatic cancer chemoprevention

C. Rao, Altaf Mohammed, S. Lightfoot, 2019, Molecular carcinogenesis.

Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery

M. Lerner, R. Postier, B. Edil, 2020, PloS one.

Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.

V. Steele, L. Kopelovich, C. Rao, 2016, American journal of cancer research.

Systemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lung

C. Rao, Yuting Zhang, S. Lightfoot, 2016, Oncogenesis.

Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)‐haploinsufficient chromosome instability model

C. Rao, Yuting Zhang, S. Lightfoot, 2016, Molecular carcinogenesis.

DNA Ploidy and Markovian Analysis of Neoplastic Progression in Experimental Pancreatic Cancer

M. Lerner, R. Postier, D. Brackett, 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Histone demethylase JMJD 2 A drives prostate tumorigenesis through transcription factor ETV 1

Aaron J. Johnson, J. Wren, S. Lightfoot, 2022 .

Oncogenic role of histone demethylase JMJD 2 A in the prostate

Aaron J. Johnson, J. Wren, S. Lightfoot, 2015 .

Upregulation of PSMD10 caused by the JMJD2A histone demethylase.

J. Wren, S. Lightfoot, R. Janknecht, 2016, International journal of clinical and experimental medicine.

Upregulation of PSMD 10 caused by the JMJD 2 A histone demethylase

J. Wren, S. Lightfoot, R. Janknecht, 2016 .

Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer.

S. Lightfoot, G. Pathuri, M. Bieniasz, 2020, Gynecologic oncology.

Luminal Antioxidants Enhance the Effects of Mesalamine in the Treatment of Chemically Induced Colitis in Rats

S. Lightfoot, R. Harty, R. Kurella, 2008, Experimental biology and medicine.

Antioxidant Therapy with N-Acetylcysteine Plus Mesalamine Accelerates Mucosal Healing in a Rodent Model of Colitis

S. Lightfoot, R. Harty, A. Siddiqui, 2006, Digestive Diseases and Sciences.

14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.

S. Lightfoot, R. Janknecht, Sook Shin, 2013, Cancer research.

Molecular and Cellular Pathobiology 14-3-3 Proteins Modulate the ETS Transcription Factor ETV 1 in Prostate Cancer

S. Lightfoot, R. Janknecht, Sook Shin, 2013 .

A Comparative Study of the Metabolic and Skeletal Response of C57BL/6J and C57BL/6N Mice in a Diet-Induced Model of Type 2 Diabetes

S. Lightfoot, Brenda J. Smith, McKale R. Davis, 2015, Journal of nutrition and metabolism.

Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice

C. Rao, Altaf Mohammed, S. Lightfoot, 2021, Neoplasia.

Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.

C. Rao, Misty Brewer, Altaf Mohammed, 2012, Neoplasia.

Ki-67 Expression in a Cervical Cancer Organotypic Model Correlates with Growth and EGF-R Expression.

S. Lightfoot, P. DiSilvestro, D. Benbrook, 1999, Journal of lower genital tract disease.

Oncogenic features of the JMJD2A histone demethylase in breast cancer.

S. Lightfoot, R. Janknecht, Sook Shin, 2012, International journal of oncology.

Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo

Yuhong Tang, S. Lightfoot, D. Benbrook, 2008, Investigational New Drugs.

Targeted sequencing of candidate genes of dyslipidemia in Punjabi Sikhs: Population-specific rare variants in GCKR promote ectopic fat deposition

D. Sanghera, S. Lightfoot, Cynthia Bejar, 2019, bioRxiv.

Evolution of Brunner gland hamartoma associated with Helicobacter pylori infection.

S. Lightfoot, R. Harty, R. Kurella, 2008, Southern medical journal.

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

M. Lerner, R. Postier, D. Brackett, 2011, Cancer research.

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer

R. Postier, P. Pantazis, C. Rao, 2013, PloS one.

The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

Altaf Mohammed, Vernon E. Steele, Venkateshwar Madka, 2010, Cancer Prevention Research.

Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo

V. Steele, L. Kopelovich, C. Rao, 2015, Cancer Prevention Research.

Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.

C. Rao, Yuting Zhang, Altaf Mohammed, 2015, Carcinogenesis.

Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas.

R. Postier, D. Brackett, C. Rao, 2010, American journal of physiology. Gastrointestinal and liver physiology.

Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL‐KrasG12D/+ mice

V. Steele, C. Rao, Lili Qian, 2012, International journal of cancer.

Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice

L. Kopelovich, C. Rao, J. Patlolla, 2015, Oncology reports.

Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib

S. Lightfoot, D. Benbrook, Yan Zhao, 2020, Cancers.

The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice

S. Lightfoot, L. McGuinness, L. Kerkhof, 2016, PloS one.

Prohibitin: A New Biomarker for Breast Tumors

A. Hollingsworth, S. Lightfoot, E. Jupe, 1997 .

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism

S. Lightfoot, R. May, C. Houchen, 2015, Oncotarget.

Dclk1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition

S. Lightfoot, R. May, C. Houchen, 2014, Oncotarget.

Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL‐22 binding protein

C. Rao, Misty Brewer, Altaf Mohammed, 2015, Molecular carcinogenesis.

Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease

M. Lerner, D. Brackett, S. Lightfoot, 2007, Journal of Inflammation.

Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

V. Steele, C. Rao, J. Patlolla, 2014, Cancer Prevention Research.

Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.

C. Rao, Yuting Zhang, Altaf Mohammed, 2016, Cancer research.

Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect.

S. Lightfoot, M. Huycke, Xingmin Wang, 2013, Translational oncology.

Brain injury: neuro-inflammation, cognitive deficit, and magnetic resonance imaging in a model of blast induced traumatic brain injury.

Megan Lerner, Yasvir Tesiram, M. Lerner, 2013, Journal of neurotrauma.

Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.

M. Lerner, R. Postier, D. Brackett, 2015, Cancer letters.

White button and shiitake mushrooms reduce the incidence and severity of collagen-induced arthritis in dilute brown non-agouti mice.

S. Lightfoot, Brenda J. Smith, E. Lucas, 2011, The Journal of nutrition.

Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer

T. Wang, S. Lightfoot, R. May, 2019, Journal of oncology.

Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer.

C. Rao, Yuting Zhang, Altaf Mohammed, 2016, Cancer research.

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer

V. Steele, C. Rao, Yuting Zhang, 2016, Scientific Reports.

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma

V. Steele, C. Rao, Misty Brewer, 2015, Oncotarget.

Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters.

S. Lightfoot, V. Mocanu, Brenda J. Smith, 2004, Atherosclerosis.

Identification of the putative intestinal stem cell marker doublecortin and CaM kinase‐like‐1 in Barrett's esophagus and esophageal adenocarcinoma

S. Meltzer, S. Lightfoot, S. Anant, 2012, Journal of gastroenterology and hepatology.

Involvement of Capsaicin-Sensitive Sensory Neurons in Stress-Induced Gastroduodenal Mucosal Injury in Rats

S. Lightfoot, R. Harty, Harry Ojeas, 2000, Digestive Diseases and Sciences.

β-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1 and RhoA/Rock Expression in A/J Mice and Growth of H460 Human Lung Cancer Cells

S. Amin, D. Desai, C. Rao, 2013, Cancer Prevention Research.

b-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH 1 A 1 andRhoA / RockExpression inA / JMiceandGrowth of H 460 Human Lung Cancer Cells

S. Amin, D. Desai, C. Rao, 2013 .

Cervical smear interpretations in women with a histologic diagnosis of severe dysplasia

S. Lightfoot, R. Zuna, A. Sienko, 2002, Cancer.

Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis

V. Steele, C. Rao, Altaf Mohammed, 2015, Cancer Prevention Research.

Raloxifene and Antiestrogenic Gonadorelin Inhibits Intestinal Tumorigenesis by Modulating Immune Cells and Decreasing Stem-like Cells

C. Rao, Misty Brewer, Altaf Mohammed, 2014, Cancer Prevention Research.

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer

V. Steele, C. Rao, Yuting Zhang, 2017, Oncotarget.

Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect.

S. Lightfoot, R. May, C. Houchen, 2008, Cancer research.

TargetingmTORandp53Signaling InhibitsMuscle Invasive Bladder Cancer In Vivo

V. Steele, L. Kopelovich, C. Rao, 2015 .

Global primary blast injury: a rat model.

M. Lerner, D. Brackett, S. Lightfoot, 1998, The Journal of the Oklahoma State Medical Association.

Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation.

M. Lerner, R. Postier, D. Brackett, 2006, Bone.

Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2

M. Lerner, D. Brackett, L. Been, 2013, BMC Genetics.

Sporadic colonic hamartomas in adults: a retrospective study.

S. Lightfoot, M. Kida, R. Harty, 2005, Gastrointestinal endoscopy.

Momordica charantia improves body weight and glucose tolerance in mice fed high fat diet.

S. Lightfoot, M. Hill, P. Perkins-Veazie, 2009 .

Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression

V. Steele, C. Rao, J. Patlolla, 2015, Oncotarget.

Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation

J. Hanas, J. Hocker, C. Rao, 2013, International journal of cancer.

Abstract 2927: Gefitinib, an EGFR inhibitor, prevents progression of PanINs to pancreatic carcinoma in a preclinical conditionalLSL-K-rasG12Dtransgenic mice model

V. Steele, C. Rao, Lili Qian, 2010 .

Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion

V. Steele, C. Rao, Yuting Zhang, 2018, Prevention Research.

The precursor of pancreatic cancer

M. Lerner, R. Postier, D. Brackett, 1995 .

Stress induced in heart and other tissues by rat dermal exposure to JP-8 fuel

M. Lerner, D. Brackett, J. Hanas, 2005, Cell Biology and Toxicology.

Molecular Carcinogenesis

Ashutosh Kumar Singh, C. Rao, Altaf Mohammed, 2019 .